{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:24:37Z","timestamp":1794263077354,"version":"4.9.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,2,15]]},"DOI":"10.2169\/internalmedicine.2053-23","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T22:11:55Z","timestamp":1686694315000},"page":"541-545","source":"Crossref","is-referenced-by-count":7,"title":["Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone"],"prefix":"10.2169","volume":"63","author":[{"given":"Ryo","family":"Kikuchi","sequence":"first","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohigashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Mitamura","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Maeda","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Takakuwa","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Fujieda","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Nephrology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 379: 348-360, 2012.","DOI":"10.1016\/S0140-6736(11)60242-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Roccatello D, Saadoun D, Ramos-Casals M, et al. Cryoglobulinaemia. Nat Rev Dis Primers 4: 11, 2018.","DOI":"10.1038\/s41572-018-0009-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Motyckova G, Murali M. Laboratory testing for cryoglobulins. Am J Hematol 86: 500-502, 2011.","DOI":"10.1002\/ajh.22023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Trejo O, Ramos-Casals M, Garcia-Carrasco M, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80: 252-262, 2001.","DOI":"10.1097\/00005792-200107000-00004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Muchtar E, Magen H, Gertz MA. How I treat cryoglobulinemia. Blood 129: 289-298, 2017.","DOI":"10.1182\/blood-2016-09-719773"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Terrier B, Karras A, Kahn JE, et al. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine (Baltimore) 92: 61-68, 2013.","DOI":"10.1097\/MD.0b013e318288925c"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Talamo G, Claxton D, Tricot G, Fink L, Zangari M. Response to bortezomib in refractory type I cryoglobulinemia. Am J Hematol 83: 883-884, 2008.","DOI":"10.1002\/ajh.21258"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Spizzo G, Mitterer M, Gunsilius E. Bortezomib for the treatment of refractory type-1 cryoglobulinaemia. Br J Haematol 150: 235-237, 2010.","DOI":"10.1111\/j.1365-2141.2010.08184.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Besada E, Vik A, Koldingsnes W, Nossent JC. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review. Int J Hematol 97: 800-803, 2013.","DOI":"10.1007\/s12185-013-1323-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ramirez GA, Campochiaro C, Salmaggi C, et al. Bortezomib in type I cryoglobulinemic vasculitis: are we acting too late? Intern Med 54: 1119-1123, 2015.","DOI":"10.2169\/internalmedicine.54.3668"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Novikov P, Moiseev S, Bulanov N, Shchegoleva E. Bortezomib in refractory ANCA-associated vasculitis: a new option? Ann Rheum Dis 75: e9, 2016.","DOI":"10.1136\/annrheumdis-2015-207947"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hankard A, Ingen-Housz-Oro S, El Karoui K, et al. IgA vasculitis with underlying monoclonal IgA gammopathy: innovative therapeutic approach targeting plasma cells. A case series. Clin Rheumatol 41: 3119-3123, 2022.","DOI":"10.1007\/s10067-022-06181-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fermand JP, Bridoux F, Dispenzieri A, et al. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 132: 1478-1485, 2018.","DOI":"10.1182\/blood-2018-04-839480"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Moreno DF, Rosinol L, Cibeira MT, Blade J, Fernandez de Larrea C. Treatment of patients with monoclonal gammopathy of clinical significance. Cancers (Basel) 13: 5131, 2021.","DOI":"10.3390\/cancers13205131"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/4\/63_2053-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T03:18:01Z","timestamp":1708139881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/4\/63_2053-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2053-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"article-number":"2053-23"}}